Trial Profile

A phase I clinical trial study of CLYM116 in healthy volunteers

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Oct 2025 New trial record
29 Sep 2025 According to Climb Bio media release, Company plans to initiate the trial in fourth quarte of 2025 with initial data anticipated mid-year 2026.
04 Sep 2025 According to Climb Bio media release, Company remains on track to file an IND or CTA for CLYM116 in the second half of 2025 and plans to initiate a Phase 1 clinical trial following completion of IND-enabling studies and subject to regulatory clearance.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com